Cargando…
Prognostic significance of pretreatment serum carcinoembryonic antigen levels in gastric cancer with pathological lymph node-negative: A large sample single-center retrospective study
AIM: To assess whether elevated serum carcinoembryonic antigen (CEA) is in the inferior prognosis for pathological lymph node-negative (pN(0)) gastric cancer (GC) patients who underwent D(2) gastrectomy. METHODS: About 469 pN(0) GC patients, who received D(2) radical gastrectomy were retrospectively...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752716/ https://www.ncbi.nlm.nih.gov/pubmed/29358864 http://dx.doi.org/10.3748/wjg.v23.i48.8562 |
_version_ | 1783290149072797696 |
---|---|
author | Xiao, Jun Ye, Zai-Sheng Wei, Sheng-Hong Zeng, Yi Lin, Zhen-Meng Wang, Yi Teng, Wen-Hao Chen, Lu-Chuan |
author_facet | Xiao, Jun Ye, Zai-Sheng Wei, Sheng-Hong Zeng, Yi Lin, Zhen-Meng Wang, Yi Teng, Wen-Hao Chen, Lu-Chuan |
author_sort | Xiao, Jun |
collection | PubMed |
description | AIM: To assess whether elevated serum carcinoembryonic antigen (CEA) is in the inferior prognosis for pathological lymph node-negative (pN(0)) gastric cancer (GC) patients who underwent D(2) gastrectomy. METHODS: About 469 pN(0) GC patients, who received D(2) radical gastrectomy were retrospectively analyzed. The X-tile plots cut-off point for CEA were 30.02 ng/mL using minimum P-value from log-rank χ(2) statistics, and pN(0) GC patients were assigned to two groups: those more than 30.02 ng/mL (n = 48; CEA-high group) and those less than 30.02 ng/mL (n = 421; CEA-low group). Clinicopathologic characteristics were compared using Pearson's χ(2) or Fisher’s exact tests, and survival curves were so manufactured using the Kaplan-Meier method. Univariate and multivariate analysis were carried out using the logistic regression method. RESULTS: The percentage of vessel carcinoma embolus (31.35% vs 17.1%) and advanced GC (T(2-4b)) (81.25% vs 65.32%) were higher in CEA-high group than CEA-low group. The CEA-positive patients had a significantly poorer prognosis than the CEA-nagetive patients in terms of overall survival (57.74% vs 90.69%, P < 0.05), and no different was found between subgroup of T category, differentiation, nerve invasion, and vessel carcinoma embolus (all P > 0.05). Multivariate survival analysis showed that CEA (OR = 4.924), and T category (OR = 2.214) were significant prognostic factors for stage pN(0) GC (all P < 0.05). Besides, only T category (OR = 1.962) was an independent hazard factor in the CEA-high group (P < 0.05). CONCLUSION: Those pretreatment serum CEA levels over 30.02 ng/mL on behalf of worse characteristics and unfavourable tumor behavior, and a poor prognosis for a nearly doubled risk of mortality in GC patients. |
format | Online Article Text |
id | pubmed-5752716 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-57527162018-01-22 Prognostic significance of pretreatment serum carcinoembryonic antigen levels in gastric cancer with pathological lymph node-negative: A large sample single-center retrospective study Xiao, Jun Ye, Zai-Sheng Wei, Sheng-Hong Zeng, Yi Lin, Zhen-Meng Wang, Yi Teng, Wen-Hao Chen, Lu-Chuan World J Gastroenterol Retrospective Study AIM: To assess whether elevated serum carcinoembryonic antigen (CEA) is in the inferior prognosis for pathological lymph node-negative (pN(0)) gastric cancer (GC) patients who underwent D(2) gastrectomy. METHODS: About 469 pN(0) GC patients, who received D(2) radical gastrectomy were retrospectively analyzed. The X-tile plots cut-off point for CEA were 30.02 ng/mL using minimum P-value from log-rank χ(2) statistics, and pN(0) GC patients were assigned to two groups: those more than 30.02 ng/mL (n = 48; CEA-high group) and those less than 30.02 ng/mL (n = 421; CEA-low group). Clinicopathologic characteristics were compared using Pearson's χ(2) or Fisher’s exact tests, and survival curves were so manufactured using the Kaplan-Meier method. Univariate and multivariate analysis were carried out using the logistic regression method. RESULTS: The percentage of vessel carcinoma embolus (31.35% vs 17.1%) and advanced GC (T(2-4b)) (81.25% vs 65.32%) were higher in CEA-high group than CEA-low group. The CEA-positive patients had a significantly poorer prognosis than the CEA-nagetive patients in terms of overall survival (57.74% vs 90.69%, P < 0.05), and no different was found between subgroup of T category, differentiation, nerve invasion, and vessel carcinoma embolus (all P > 0.05). Multivariate survival analysis showed that CEA (OR = 4.924), and T category (OR = 2.214) were significant prognostic factors for stage pN(0) GC (all P < 0.05). Besides, only T category (OR = 1.962) was an independent hazard factor in the CEA-high group (P < 0.05). CONCLUSION: Those pretreatment serum CEA levels over 30.02 ng/mL on behalf of worse characteristics and unfavourable tumor behavior, and a poor prognosis for a nearly doubled risk of mortality in GC patients. Baishideng Publishing Group Inc 2017-12-28 2017-12-28 /pmc/articles/PMC5752716/ /pubmed/29358864 http://dx.doi.org/10.3748/wjg.v23.i48.8562 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Retrospective Study Xiao, Jun Ye, Zai-Sheng Wei, Sheng-Hong Zeng, Yi Lin, Zhen-Meng Wang, Yi Teng, Wen-Hao Chen, Lu-Chuan Prognostic significance of pretreatment serum carcinoembryonic antigen levels in gastric cancer with pathological lymph node-negative: A large sample single-center retrospective study |
title | Prognostic significance of pretreatment serum carcinoembryonic antigen levels in gastric cancer with pathological lymph node-negative: A large sample single-center retrospective study |
title_full | Prognostic significance of pretreatment serum carcinoembryonic antigen levels in gastric cancer with pathological lymph node-negative: A large sample single-center retrospective study |
title_fullStr | Prognostic significance of pretreatment serum carcinoembryonic antigen levels in gastric cancer with pathological lymph node-negative: A large sample single-center retrospective study |
title_full_unstemmed | Prognostic significance of pretreatment serum carcinoembryonic antigen levels in gastric cancer with pathological lymph node-negative: A large sample single-center retrospective study |
title_short | Prognostic significance of pretreatment serum carcinoembryonic antigen levels in gastric cancer with pathological lymph node-negative: A large sample single-center retrospective study |
title_sort | prognostic significance of pretreatment serum carcinoembryonic antigen levels in gastric cancer with pathological lymph node-negative: a large sample single-center retrospective study |
topic | Retrospective Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752716/ https://www.ncbi.nlm.nih.gov/pubmed/29358864 http://dx.doi.org/10.3748/wjg.v23.i48.8562 |
work_keys_str_mv | AT xiaojun prognosticsignificanceofpretreatmentserumcarcinoembryonicantigenlevelsingastriccancerwithpathologicallymphnodenegativealargesamplesinglecenterretrospectivestudy AT yezaisheng prognosticsignificanceofpretreatmentserumcarcinoembryonicantigenlevelsingastriccancerwithpathologicallymphnodenegativealargesamplesinglecenterretrospectivestudy AT weishenghong prognosticsignificanceofpretreatmentserumcarcinoembryonicantigenlevelsingastriccancerwithpathologicallymphnodenegativealargesamplesinglecenterretrospectivestudy AT zengyi prognosticsignificanceofpretreatmentserumcarcinoembryonicantigenlevelsingastriccancerwithpathologicallymphnodenegativealargesamplesinglecenterretrospectivestudy AT linzhenmeng prognosticsignificanceofpretreatmentserumcarcinoembryonicantigenlevelsingastriccancerwithpathologicallymphnodenegativealargesamplesinglecenterretrospectivestudy AT wangyi prognosticsignificanceofpretreatmentserumcarcinoembryonicantigenlevelsingastriccancerwithpathologicallymphnodenegativealargesamplesinglecenterretrospectivestudy AT tengwenhao prognosticsignificanceofpretreatmentserumcarcinoembryonicantigenlevelsingastriccancerwithpathologicallymphnodenegativealargesamplesinglecenterretrospectivestudy AT chenluchuan prognosticsignificanceofpretreatmentserumcarcinoembryonicantigenlevelsingastriccancerwithpathologicallymphnodenegativealargesamplesinglecenterretrospectivestudy |